Clinically, detecting a TERT promoter mutation in an IDH-wild type astrocytic glioma is crucial for diagnosing glioblastoma.2,43 For diagnostic biopsies, sampling hypermetabolic lesions using PET imaging guidance is advisable, emphasizing the significance of our findings in clinical practice. This evidence concerns the gene TERT and glioblastoma.